Glenmark Pharmaceuticals reported a 3.3 per cent growth in consolidated net profit for the April-June period of 2015-16.Net profit stood at Rs 190 crore against Rs 184 crore a year ago. Revenue was up 13 per cent to Rs 1,655 crore against Rs 1,457 crore in the same period last financial year. The previous result had a one-time gain of Rs 30 crore from product licensing.
 "Glenmark profit up 3.3%")
